Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to possibly further improve the clinical outcome and explore the
incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in
GnRH antagonist IVF/ICSI cycles